A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer

Mantini, 2012, Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study, Radiother Oncol, 105, 161, 10.1016/j.radonc.2012.09.006 Wang, 2012, Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer, Lung Cancer, 77, 89, 10.1016/j.lungcan.2012.02.011 Lopez Guerra, 2011, Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapy, Radiother Oncol, 101, 271, 10.1016/j.radonc.2011.08.039 Mitrica, 2012, The dual action of epigallocatechin gallate (EGCG), the main constituent of green tea, against the deleterious effects of visible light and singlet oxygen-generating conditions as seen in yeast cells, Molecules, 17, 10355, 10.3390/molecules170910355 Niu, 2013, The phytochemical, EGCG, extends lifespan by reducing liver and kidney function damage and improving age-associated inflammation and oxidative stress in healthy rats, Aging Cell, 10.1111/acel.12133 Richi, 2012, Radio-modulatory effects of green tea catechin EGCG on pBR322 plasmid DNA and murine splenocytes against gamma-radiation induced damage, Mutat Res, 747, 62, 10.1016/j.mrgentox.2012.04.002 Wu, 2012, Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro, Toxicol Appl Pharmacol, 258, 166, 10.1016/j.taap.2011.10.018 Hsu, 2011, Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFκB pathway in the Noble rat model, J Nutr Biochem, 22, 502, 10.1016/j.jnutbio.2010.04.006 Qi, 2010, Reactive oxygen species scavenging activities and inhibition on DNA oxidative damage of dimeric compounds from the oxidation of (-)-epigallocatechin-3-O-gallate, Fitoterapia, 81, 205, 10.1016/j.fitote.2009.09.004 Yoshioka, 1997, Beta ray-induced scission of DNA in tritiated water and protection by a green tea percolate and (-)-epigallocatechin gallate, Biosci Biotechnol Biochem, 61, 1560, 10.1271/bbb.61.1560 Hu, 2011, Protective role of tea polyphenols in combination against radiation-induced haematopoietic and biochemical alterations in mice, Phytother Res, 25, 1761, 10.1002/ptr.3483 Lee, 2008, Modification of gamma-radiation response in mice by green tea polyphenols, Phytother Res, 22, 1380, 10.1002/ptr.2507 Peng, 2011, Tea polyphenols protect against irradiation-induced injury in submandibular glands’ cells: a preliminary study, Arch Oral Biol, 56, 738, 10.1016/j.archoralbio.2010.12.009 Zhang, 2012, Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy, Curr Mol Med, 12, 163, 10.2174/156652412798889063 Pijls-Johannesma, 2009, High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL, Radiother Oncol, 91, 443, 10.1016/j.radonc.2009.02.010 Kerksick, 2013, Changes in skeletal muscle proteolytic gene expression after prophylactic supplementation of EGCG and NAC and eccentric damage, Food Chem Toxicol, 10.1016/j.fct.2013.01.026 Nijkamp, 2013, Relating acute esophagitis to radiotherapy dose using FDG-PET in concurrent chemo-radiotherapy for locally advanced non-small cell lung cancer, Radiother Oncol, 106, 118, 10.1016/j.radonc.2012.09.024 Zhu, 2010, Analysis of acute radiation-induced esophagitis in non-small-cell lung cancer patients using the Lyman NTCP model, Radiother Oncol, 97, 449, 10.1016/j.radonc.2010.09.025 Guerra, 2012, Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer, Radiother Oncol, 105, 299, 10.1016/j.radonc.2012.08.014 Rose, 2009, Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy, Radiother Oncol, 91, 282, 10.1016/j.radonc.2008.09.010 Feng, 2012, A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy, Int J Radiat Oncol Biol Phys, 83, 1441, 10.1016/j.ijrobp.2011.10.020 Hill, 2011, Investigations into the role of inflammation in normal tissue response to irradiation, Radiother Oncol, 101, 73, 10.1016/j.radonc.2011.06.017 Lawrence, 2013, The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801, Lung Cancer, 80, 298, 10.1016/j.lungcan.2013.02.008 Singh, 2011, Green tea catechin, epigallocatechin-3gallate (EGCG): mechanisms, perspectives and clinical applications, Biochem Pharmacol, 82, 1807, 10.1016/j.bcp.2011.07.093 de Rosa, 2012, Low doses of selenium specifically stimulate the repair of oxidative DNA damage in LNCaP prostate cancer cells, Free Radic Res, 46, 105, 10.3109/10715762.2011.647009 Hallqvist, 2012, Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab-pooled results from two prospective clinical trials, Radiother Oncol, 104, 39, 10.1016/j.radonc.2012.05.006 Groselj, 2013, Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression, Radiother Oncol, 10.1016/j.radonc.2013.06.021 Trudel, 2013, A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer, Gynecol Oncol, 10.1016/j.ygyno.2013.08.019 Poudenx, 2012, Cisplatin-docetaxel induction plus concurrent 3-D conformal radiotherapy and weekly chemotherapy for locally advanced non-small cell lung cancer patients: a phase II trial, Oncology, 83, 321, 10.1159/000342081 Rodríguez, 2009, Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy, Int J Radiat Oncol Biol Phys, 73, 810, 10.1016/j.ijrobp.2008.04.064 Uyterlinde, 2013, Prognostic parameters for acute esophagus toxicity in intensity modulated radiotherapy and concurrent chemotherapy for locally advanced non-small cell lung cancer, Radiother Oncol, 107, 392, 10.1016/j.radonc.2013.04.012